Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Efficacy and Safety Study of Escitalopram Augmentation in Treatment Resistant Schizophrenia

This study has been completed.
Sponsor:
Collaborator:
Forest Laboratories
Information provided by:
Emory University
ClinicalTrials.gov Identifier:
NCT00231335
First received: October 3, 2005
Last updated: December 6, 2010
Last verified: March 2006
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2007
  Estimated Primary Completion Date: No date given